Ocuphire Pharma Total Liabilities 2010-2024 | IRD
Ocuphire Pharma total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Ocuphire Pharma Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $3 |
| 2021 | $4 |
| 2020 | $31 |
| 2019 | $9 |
| 2018 | $5 |
| 2017 | $12 |
| 2016 | $4 |
| 2015 | $6 |
| 2014 | $7 |
| 2013 | $7 |
| 2012 | $5 |
| 2011 | $3 |
| 2010 | $6 |
| 2009 | $5 |
| Ocuphire Pharma Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4 |
| 2024-03-31 | $6 |
| 2023-12-31 | $4 |
| 2023-09-30 | $4 |
| 2023-06-30 | $6 |
| 2023-03-31 | $4 |
| 2022-12-31 | $3 |
| 2022-09-30 | $3 |
| 2022-06-30 | $3 |
| 2022-03-31 | $3 |
| 2021-12-31 | $4 |
| 2021-09-30 | $3 |
| 2021-06-30 | $3 |
| 2021-03-31 | $2 |
| 2020-12-31 | $31 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $2 |
| 2019-12-31 | $9 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $5 |
| 2018-09-30 | $7 |
| 2018-06-30 | $7 |
| 2018-03-31 | $8 |
| 2017-12-31 | $12 |
| 2017-09-30 | $9 |
| 2017-06-30 | $12 |
| 2017-03-31 | $18 |
| 2016-12-31 | $4 |
| 2016-09-30 | $6 |
| 2016-06-30 | $5 |
| 2016-03-31 | $8 |
| 2015-12-31 | $6 |
| 2015-09-30 | $5 |
| 2015-06-30 | $6 |
| 2015-03-31 | $7 |
| 2014-12-31 | $7 |
| 2014-09-30 | $8 |
| 2014-06-30 | $9 |
| 2014-03-31 | $13 |
| 2013-12-31 | $7 |
| 2013-09-30 | $6 |
| 2013-06-30 | $6 |
| 2013-03-31 | $5 |
| 2012-12-31 | $5 |
| 2012-09-30 | $3 |
| 2012-06-30 | $2 |
| 2012-03-31 | $3 |
| 2011-12-31 | $3 |
| 2011-09-30 | $9 |
| 2011-06-30 | $10 |
| 2011-03-31 | $10 |
| 2010-12-31 | $6 |
| 2010-09-30 | $2 |
| 2010-06-30 | $3 |
| 2010-03-31 | $2 |
| 2009-12-31 | $5 |
| 2009-09-30 | $2 |
| 2009-06-30 | $2 |
| 2009-03-31 | $2 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |